VEGFA and cancer: A reasonable explanation was that chemotherapy failed to inhibit angiogenesis in the presence of a reactive resistance, which was mediated by the HIF-1/VEGF pathway in cancer cells, while antibodies targeting VEGF blocked the reactive resistance, sensitizing cancer cells to chemotherapy [39].